| ADMA Biologics, Inc. | Common | $542K | 0.3% | 60,200 SH | New |
| Agios Pharmaceutical, Inc. | Common | $3.1M | 1.9% | 93,058 SH | New |
| Alkermes PLC | Common | $4.2M | 2.5% | 120,000 SH | New |
| AllianceBernstein Holding L.P. | Common | $1.8M | 1.1%Prev: 0.9% | 48,000 SH | Decreased |
| Alphabet Inc CL A | Common | $86K | 0.1%Prev: 0.0% | 300 SH | Increased |
| Alphabet Inc-Cl C | Common | $26.2M | 15.6%Prev: 8.3% | 91,420 SH | Increased-20,800 SH |
| Amazon.com Inc. | Common | $62K | 0.0%Prev: 0.0% | 300 SH | Increased |
| Apollo Global Management, Inc. | Common | $25.1M | 14.9%Prev: 14.5% | 225,000 SH | Decreased |
| Apple Inc. | Common | $633K | 0.4%Prev: 0.3% | 2,494 SH | Increased |
| Arcellx Inc | Common | $2.2M | 1.3%Prev: 0.5% | 19,433 SH | Increased+4,433 SH |
| Arcus Biosciences, Inc. | Common | $1.8M | 1.0%Prev: 0.0% | 81,241 SH | Increased+69,241 SH |
| Ardelyx, Inc. | Common | $1.2M | 0.7%Prev: 1.1% | 207,000 SH | Decreased-286,807 SH |
| AtriCure, Inc. | Common | $1.5M | 0.9%Prev: 0.4% | 51,400 SH | Increased+26,780 SH |
| Biogen Inc. | Common | $733K | 0.4% | 4,000 SH | New |
| Biohaven Pharmaceutical Holding Co. Ltd | Common | $514K | 0.3% | 60,720 SH | New |
| Blackstone Group LP | Common | $24K | 0.0%Prev: 0.0% | 210 SH | Decreased |
| Bridgebio Pharma, Inc. | Common | $6.7M | 4.0% | 90,000 SH | New |
| Brightstar Lottery PLC | Common | $32K | 0.0% | 2,500 SH | New |
| Bristol-Myers Squibb Company | Common | $826K | 0.5%Prev: 0.5% | 13,622 SH | Decreased-5,378 SH |
| Broadcom, Inc. | Common | $220K | 0.1%Prev: 0.1% | 710 SH | Increased |
| Canadian Natural Resources Limited | Common | $819K | 0.5%Prev: 0.2% | 16,800 SH | Increased |
| Catalyst Pharmaceuticals, Inc. | Common | $3.0M | 1.8%Prev: 2.4% | 120,000 SH | Decreased-92,000 SH |
| Centessa Pharmaceuticals PLC | Common | $1.5M | 0.9% | 39,000 SH | New |
| Cogent Biosciences Inc. | Common | $4.0M | 2.4%Prev: 0.6% | 104,000 SH | Increased-109,302 SH |
| Connect Biopharma Holdings Limited | Common | $1.0M | 0.6% | 387,835 SH | New |
| Corteva, Inc. | Common | $101K | 0.1%Prev: 0.3% | 1,206 SH | Decreased-9,845 SH |
| Cullinan Therapeutics, Inc. | Common | $344K | 0.2% | 24,200 SH | New |
| Cybin Inc | Common | $1.7M | 1.0%Prev: 0.2% | 350,000 SH | Increased+283,120 SH |
| Cytokinetics, Incorporated | Common | $1.6M | 0.9% | 23,644 SH | New |
| Danaher Corporation | Common | $34K | 0.0%Prev: 0.0% | 180 SH | Decreased |
| DocGo, Inc. | Common | $1.7M | 1.0%Prev: 3.8% | 2,670,850 SH | Decreased-400,000 SH |
| Dow Inc. | Common | $50K | 0.0%Prev: 0.0% | 1,206 SH | Increased |
| DuPont de Nemours, Inc. | Common | $173K | 0.1%Prev: 0.3% | 3,767 SH | Decreased-5,651 SH |
| Eastern Bankshares Inc | Common | $98K | 0.1%Prev: 0.0% | 5,000 SH | Increased |
| Evolus, Inc. | Common | $408K | 0.2% | 99,338 SH | New |
| FS KKR Capital Corp. | Common | $29K | 0.0%Prev: 0.0% | 2,875 SH | Decreased |
| GE HealthCare Technologies Inc | Common | $4K | 0.0%Prev: 0.0% | 50 SH | Decreased |
| International Business Machines | Common | $519K | 0.3%Prev: 0.3% | 2,142 SH | Decreased |
| Invivyd, Inc. | Common | $130K | 0.1% | 100,000 SH | New |
| Iovance Biotherapeutics, Inc. | Common | $5.6M | 3.3% | 1,600,000 SH | New |
| iShares Biotechnology ETF | Common | $929K | 0.6% | 5,500 SH | New |
| iShares Russell Mid-Cap Growth | Common | $89K | 0.1%Prev: 0.0% | 695 SH | Increased |
| Janus Henderson AAA CLO ETF | Common | $4.7M | 2.8%Prev: 13.2% | 93,528 SH | Decreased-458,235 SH |
| Jasper Therapeutics, Inc. | Common | $141K | 0.1% | 160,789 SH | New |
| Johnson & Johnson | Common | $1.2M | 0.7%Prev: 0.1% | 4,922 SH | Increased+4,000 SH |
| JPMorgan Chase & Co. | Common | $5.7M | 3.4%Prev: 2.4% | 19,477 SH | Increased-1,508 SH |
| Kimberly-Clark Corporation | Common | $232K | 0.1%Prev: 0.4% | 2,400 SH | Decreased-3,600 SH |
| Kura Oncology, Inc. | Common | $429K | 0.3% | 52,767 SH | New |
| Kyndryl Holdings Inc. | Common | $6K | 0.0%Prev: 0.0% | 428 SH | Decreased |
| Legacy Housing Corporation | Common | $82K | 0.0%Prev: 0.1% | 4,000 SH | Decreased-2,500 SH |
| LENZ Therapeutics, Inc. | Common | $309K | 0.2% | 33,732 SH | New |
| LPL Financial Holdings Inc. | Common | $5.0M | 3.0% | 16,500 SH | New |
| Madrigal Pharmaaceuticals, Inc. | Common | $1.0M | 0.6% | 2,000 SH | New |
| Mereo BioPharm Group PLC | Common | $99K | 0.1%Prev: 0.3% | 300,337 SH | Decreased-19,000 SH |
| Microsoft Corporation | Common | $592K | 0.4%Prev: 0.3% | 1,600 SH | Decreased |
| Mondelez International, Inc. | Common | $173K | 0.1% | 3,000 SH | New |
| Nvidia Corp | Common | $223K | 0.1%Prev: 0.1% | 1,280 SH | Increased |
| Occidental Petroleum Corporation | Common | $30K | 0.0%Prev: 0.0% | 469 SH | Increased |
| Occidential Pertro Wts exp. 8/3/27 | Common | $4K | 0.0%Prev: 0.0% | 194 SH | |
| Orchestra Biomed Holdings, Inc. | Common | $1.1M | 0.6% | 253,651 SH | New |
| Pelthos Therapeutics, Inc. | Common | $443K | 0.3% | 21,073 SH | New |
| Pfizer Inc. | Common | $908K | 0.5%Prev: 3.0% | 32,337 SH | Decreased-222,200 SH |
| Protagonist Therapeutics, Inc | Common | $6.6M | 4.0%Prev: 1.7% | 63,000 SH | Increased-13,000 SH |
| Quanta Services, Inc. | Common | $97K | 0.1%Prev: 0.0% | 176 SH | Increased |
| Rain Enhancement Technologies Holdco Inc | Common | $258K | 0.2% | 101,686 SH | New |
| Relmada Therapeutics, Inc. | Common | $3.1M | 1.8% | 439,300 SH | New |
| Rezolute, Inc. | Common | $1.1M | 0.7% | 370,000 SH | New |
| Ryman Hospitality Properties, Inc. | Common | $221K | 0.1%Prev: 0.5% | 2,400 SH | Decreased-9,600 SH |
| Salesforce, Inc. | Common | $14K | 0.0%Prev: 0.0% | 77 SH | Decreased |
| Solid Bioscience Inc. | Common | $339K | 0.2%Prev: 0.2% | 47,143 SH | Decreased-84,857 SH |
| SPDR S&P Biotech ETF | Common | $1.9M | 1.1%Prev: 0.5% | 15,000 SH | Increased+1,357 SH |
| Starwood Property Trust, Inc. | Common | $7K | 0.0%Prev: 0.0% | 400 SH | Decreased |
| Syndax Pharmaceutical, Inc. | Common | $9.9M | 5.9%Prev: 0.7% | 422,000 SH | Increased+294,000 SH |
| TG Therapeutics, Inc. | Common | $3.0M | 1.8% | 90,001 SH | New |
| The Panagram BBB-B CLO ETF | Common | $1.2M | 0.7%Prev: 0.6% | 47,807 SH | Decreased |
| Thermo Fisher Scientific, Inc. | Common | $22K | 0.0%Prev: 0.0% | 45 SH | Decreased |
| Travere Therapeutics, Inc. | Common | $4.2M | 2.5%Prev: 1.9% | 140,633 SH | Increased-87,367 SH |
| Ultragenyx Pharmaceutical Inc. | Common | $693K | 0.4%Prev: 0.8% | 33,069 SH | Decreased-14,931 SH |
| United Healthcare Corp. | Common | $15K | 0.0%Prev: 0.0% | 57 SH | Decreased |
| United Rental, Inc. | Common | $57K | 0.0%Prev: 0.0% | 78 SH | Increased |
| Vera Therapeutics, Inc. | Common | $1.0M | 0.6%Prev: 0.1% | 26,000 SH | Increased+16,000 SH |
| Verastem Inc. | Common | $551K | 0.3% | 104,000 SH | New |
| Viridian Therapeutics, Inc. | Common | $3.5M | 2.1%Prev: 0.2% | 181,000 SH | Increased+151,000 SH |
| Wabtec Corporation | Common | $1K | 0.0%Prev: 0.0% | 6 SH | Increased |
| Wave Life Science Ltd. | Common | $290K | 0.2%Prev: 0.0% | 40,000 SH | Increased+30,000 SH |
| Xeris Biopharma Holdings, Inc. | Common | $6.1M | 3.7%Prev: 2.9% | 1,060,000 SH | Increased-50,000 SH |